Every human is different.
So a drug cannot have the same effect on all people. A treatment can be very beneficial for one person and for another it can be pointless, or even toxic, causing significant side effects. This is because each person has a different genetic background, which can be essential to the type of medication they need to receive.
But how can we separate the beneficial drugs from the toxic ones for our own body, so that we can immediately receive the right treatment, avoiding experimentations and serious side effects?
A new molecular test, called MyTheragene, which is performed once in our lives and based on the science of pharmacogenomics, provides the answers between 500 different drugs, making it easier for the doctor and patient to choose a safe, individualized and effective treatment with obvious benefits for the patient. Among these substances are many common prescription drugs such as anti-inflammatory, analgesic, antipyretic, but also drugs used to treat heart, psychiatric and neurological diseases, as well as cancer.
The US Food and Drug Administration (FDA) has already included pharmacogenomic information in the enclosures of many drugs, highlighting the need to adapt prescription substances to a person's genetic background.
This molecular analysis is now the choice of millions of people around the world for individualized treatment, it is called MyTheragene and is also performed in Eastern and Southern Europe and Western Asia, in the specialized molecular analysis laboratories of the company Genekor Medical SA.